Anthem (ANTM) Raised LT Strategy Is Still Dependent On IngenioRx, PT To $364 At Cowen
Tweet Send to a Friend
Cowen analyst, Charles Rhyee, reiterated his Outperform rating on Anthem (NYSE: ANTM) and raised his price target to $364 from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
